tert-Butyl 4-aminopiperazine-1-carboxylate, 95.0%, 10g

1-[4-(Trifluoromethyl)phenyl]cyclopropanecarbonitrile, 95.0%, 1g

1-(5-Nitropyridin-2-yl)piperidin-4-aminehydrochloride, 95.0%, 1g

2-Oxa-7-azaspiro[4.4]nonane hemioxalate, 98%, 10g

2-Bromo-3-methylbenzo[b]thiophene, 97%, 250mg

Methyl 6-amino-5-hydroxynicotinate, 95.0%, 1g

2-(3,5-DIMETHYLPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95.0%, 5g

N-Benzyl-N,N-diethylethanaminium tetrahydroborate, 90.0%, 1g

3-(2-(2-(2-AMINOETHOXY)ETHOXY)ETHOXY)PROPANOIC ACID HYDROCHLORIDE, 95%, 1g

7-Bromo-2H-benzo[b][1,4]thiazin-3(4H)-one, 95.0%, 1g

N-2-Nitrophenylsulfenyl-L-isoleucine Dicyclohexylammonium Salt>98.0%(HPLC)1g

Screw vials conical sterile, 0.5 ml, 200 Piece(s)

Lead(II) acetate, basic, min. 33% PbO, pa, ACS, 1 kg, plastic packaging.